These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22139986)

  • 1. [Liver transplantation - when and for whom it should be performed].
    Morell B; Dufour JF
    Ther Umsch; 2011 Dec; 68(12):707-13. PubMed ID: 22139986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of MELD in the allocation of priority for liver transplantation candidates].
    Colmenero J; Castro-Narro G; Navasa M
    Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.
    Kanwal F; Dulai GS; Spiegel BM; Yee HF; Gralnek IM
    Aliment Pharmacol Ther; 2005 Jan; 21(2):169-77. PubMed ID: 15679767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease-epidemiology formula and model for end-stage liver disease score in the assessment of renal function in candidates for liver transplantation.
    Tinti F; Lai S; Umbro I; Mordenti M; Barile M; Ginanni Corradini S; Rossi M; Poli L; Nofroni I; Berloco PB; Mitterhofer AP
    Transplant Proc; 2010 May; 42(4):1229-32. PubMed ID: 20534268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional split liver transplantation for two adult recipients: a recent experience in a single European center.
    Cescon M; Grazi GL; Ravaioli M; Ercolani G; Del Gaudio M; Vivarelli M; Cucchetti A; Zanello M; Vetrone G; Lauro A; Pinna AD
    Transplantation; 2009 Nov; 88(9):1117-22. PubMed ID: 19898208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.
    Dutkowski P; Oberkofler CE; Béchir M; Müllhaupt B; Geier A; Raptis DA; Clavien PA
    Liver Transpl; 2011 Jun; 17(6):674-84. PubMed ID: 21618688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of waitlisted patients for liver transplantation at a liver transplantation unit in the city of Ribeirão Preto, São Paulo, Brazil, especially considering Child and Model for End Stage Liver Disease (MELD) scores.
    Teixeira AC; Souza FF; Sankarankutty AK; Martinelli AL; Castro E Silva O
    Transplant Proc; 2007 Mar; 39(2):387-9. PubMed ID: 17362738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.
    Silberhumer GR; Pokorny H; Hetz H; Herkner H; Rasoul-Rockenschaub S; Soliman T; Wekerle T; Berlakovich GA; Steininger R; Muehlbacher F
    Transplantation; 2007 Mar; 83(5):588-92. PubMed ID: 17353779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation organ allocation between Child and MELD.
    Graziadei I
    Wien Med Wochenschr; 2006 Jul; 156(13-14):410-5. PubMed ID: 16937044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.
    Desai NM; Mange KC; Crawford MD; Abt PL; Frank AM; Markmann JW; Velidedeoglu E; Chapman WC; Markmann JF
    Transplantation; 2004 Jan; 77(1):99-106. PubMed ID: 14724442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
    Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP
    Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.